CorMedix (CRMD) Receivables (2013 - 2025)
CorMedix (CRMD) reported Receivables of $171.2 million for Q4 2025, up 231.5% on a YoY basis from $51.7 million in Q4 2024, and up 7.98% sequentially from $158.6 million in Q3 2025.
CorMedix (CRMD) Receivables (2013 - 2025) Analysis & Trends
CorMedix (CRMD) has 12 years of Receivables data on file, last reported at $171.2 million in Q4 2025.
- For the quarter ending Q4 2025, Receivables rose 231.5% year-over-year to $171.2 million; the trailing twelve-month figure through Dec 2025 stood at $171.2 million (up 231.5% YoY), and the FY2025 full-year result was $171.2 million, up 231.5% from the prior year.
- Receivables grew to $171.2 million in Q4 2025, from $158.6 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $171.2 million in Q4 2025 to a low of $2975.0 in Q1 2022.
- A 4-year average of $45.2 million and a median of $17.4 million in 2024 frame the typical range for Receivables.
- Across the five-year window, Receivables sank 93.18% in 2022 and soared 5975.24% in 2025, its largest moves.
- Tracing CRMD's Receivables over 4 years: stood at $45368.0 in 2021, then plunged by 93.44% to $2975.0 in 2022, then soared by 1736168.91% to $51.7 million in 2024, then jumped by 231.5% to $171.2 million in 2025.
- Business Quant data shows CRMD's Receivables at $171.2 million in Q4 2025, $158.6 million in Q3 2025, and $42.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | CorMedix | 546.82 Mn | 391.62 Mn | 107.31 Mn | 171.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 171.23 Mn |
| Sep 30, 2025 | 158.57 Mn |
| Jun 30, 2025 | 42.91 Mn |
| Mar 31, 2025 | 54.61 Mn |
| Dec 31, 2024 | 51.65 Mn |
| Sep 30, 2024 | 17.39 Mn |
| Jun 30, 2024 | 706,337.00 |
| Mar 31, 2022 | 2,975.00 |
| Dec 31, 2021 | 45,368.00 |
| Jun 30, 2021 | 3,180.00 |
| Mar 31, 2021 | 43,606.00 |
| Dec 31, 2020 | 3,357.00 |
| Sep 30, 2020 | 6,118.00 |
| Jun 30, 2020 | 11,030.00 |
| Mar 31, 2020 | 7,311.00 |
| Dec 31, 2019 | 35.00 |
| Sep 30, 2019 | 3,956.00 |
| Mar 31, 2019 | 34,381.00 |
| Dec 31, 2018 | 10,904.00 |
| Sep 30, 2018 | 302,384.00 |